Home/Filings/4/0001694665-20-000070
4//SEC Filing

Liu Xiaoli Jacqueline 4

Accession 0001694665-20-000070

CIK 0001694665other

Filed

Jul 13, 8:00 PM ET

Accepted

Jul 14, 4:26 PM ET

Size

5.3 KB

Accession

0001694665-20-000070

Insider Transaction Report

Form 4
Period: 2020-07-10
Liu Xiaoli Jacqueline
Principal Accounting Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-07-10+30,00030,000 total
    Exercise: $4.20Exp: 2030-07-10Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 75% of the shares (22,500) on July 10, 2022 and as to 25% of the shares (7,500) on July 10, 2023.

Issuer

Evelo Biosciences, Inc.

CIK 0001694665

Entity typeother

Related Parties

1
  • filerCIK 0001805198

Filing Metadata

Form type
4
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 4:26 PM ET
Size
5.3 KB